Tyrosine and Gabapentin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tyrosine (tyrosine) and Gabapentin (gabapentin). Common drug interactions include abdominal discomfort among females and arthralgia among males.

The phase IV clinical study analyzes what interactions people have when they take Tyrosine and Gabapentin. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.

What is Tyrosine?

Tyrosine has active ingredients of tyrosine. It is often used in hypothyroidism. eHealthMe is studying from 830 Tyrosine users. Check the latest studies of Tyrosine.

What is Gabapentin?

Gabapentin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 322,983 Gabapentin users. Check the latest studies of Gabapentin.

On Jul, 08, 2026

36 people who take Tyrosine and Gabapentin together, and have interactions are studied.

Tyrosine and Gabapentin drug interactions.

What are the common drug interactions of Tyrosine and Gabapentin, by gender? *:

female:

Abdominal discomfort
Amphetamines positive
Asthma
Abdominal pain
Adverse event
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Ataxia (loss of full control of bodily movements)
Attention deficit hyperactivity disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness)
Back pain
Balance disorder

male:

Arthralgia (joint pain)
Fatigue (feeling of tiredness)
Anxiety
Asthenia (weakness)
Asthma
Blood glucose increased
Blood pressure increased
Bradycardia (abnormally slow heart action)
Cardiac disorder
Cataplexy (loss of muscle tone accompanied by full conscious awareness)

What are the common drug interactions of Tyrosine and Gabapentin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Abdominal discomfort
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Anxiety
Arthralgia (joint pain)
Asthenia (weakness)
Attention deficit hyperactivity disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness)
Chapped lips (cracking, fissuring, and peeling of the skin f lip)
Diarrhoea
Dissociation
Dizziness

30-39:

Hyperaesthesia
Hypoaesthesia (reduced sense of touch or sensation)
Muscle twitching
Nail disorder (disease of nail)
Pain in extremity
Rash generalised (rash on most of body parts)
Tendon rupture (tear of tendon)
Abdominal pain upper
Skin exfoliation (removal of the oldest dead skin cells)
Abdominal pain

40-49:

Heart rate increased
Migraine (headache)
Muscle spasms (muscle contraction)
Upper respiratory tract infection

50-59:

Drug ineffective
Back pain
Dry throat
Headache (pain in head)
Hepatic pain (pain in liver)
Injection site urticaria (rash of round, red welts on the skin at injection site)
Insomnia (sleeplessness)
Muscle spasms (muscle contraction)
Myalgia (muscle pain)
Oral surgery

60+:

Headache (pain in head)
Neuropathy peripheral (surface nerve damage)
Neck pain
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Speech disorder
Stress fracture (fracture of a bone caused by repeated (rather than sudden) mechanical stress)
Abdominal distension
Adverse event
Anxiety
Arthritis (form of joint disorder that involves inflammation of one or more joints)

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 8 people, 22.22%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 6 people, 16.67%
Drowsiness: 3 people, 8.33%
Thyroid Diseases: 2 people, 5.56%
Stiff Person Syndrome: 2 people, 5.56%
Psoriasis (immune-mediated disease that affects the skin): 2 people, 5.56%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 2 people, 5.56%
Neuropathy Peripheral (surface nerve damage): 2 people, 5.56%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 5.56%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Tyrosine and Gabapentin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously